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Abstract
Background: The asbestos-like toxicity of some engineered carbon nanotubes (CNT), notably their capacity to
induce mesothelioma, is a serious cause of concern for public health. Here we show that carcinogenic CNT induce
an early and sustained immunosuppressive response characterized by the accumulation of monocytic Myeloid
Derived Suppressor Cells (M-MDSC) that counteract effective immune surveillance of tumor cells.
Methods: Wistar rats and C57BL/6 mice were intraperitoneally injected with carcinogenic multi-walled Mitsui-7
CNT (CNT-7) or crocidolite asbestos. Peritoneal mesothelioma development and immune cell accumulation were
assessed until 12 months. Leukocyte sub-populations were identified by recording expression of CD11b/c and
His48 by flow cytometry. The immunosuppressive activity on T lymphocytes of purified peritoneal leukocytes was
assessed in a co-culture assay with activated spleen cells.
Results: We demonstrate that long and short mesotheliomagenic CNT-7 injected in the peritoneal cavity of rats
induced, like asbestos, an early and selective accumulation of monocytic cells (CD11b/cint and His48hi) which
possess the ability to suppress polyclonal activation of T lymphocytes and correspond to M-MDSC. Peritoneal
M-MDSC persisted during the development of peritoneal mesothelioma in CNT-7-treated rats but were only
transiently recruited after non-carcinogenic CNT (CNT-M, CNT-T) injection. Peritoneal M-MDSC did not accumulate
in mice which are resistant to mesothelioma development.
Conclusions: Our data provide new insights into the initial pathogenic events induced by CNT, adding a new
component to the adverse outcome pathway leading to mesothelioma development. The specificity of the
M-MDSC response after carcinogenic CNT exposure highlights the interest of this response for detecting the
ability of new nanomaterials to cause cancer.
Keywords: Immunosuppression, Inflammation, Mesothelioma, Myeloid cells, Carbon nanotubes, Asbestos,
Crocidolite, Fibers, Rats and mice
Abbreviations: CNT, Carbon nanotubes; CNT-7, Multi-walled Mitsui-7 CNT; CNT-M, Muller carbon nanotubes;
CNT-T, Tangled carbon nanotubes; Asb, Crocidolite asbestos; SiO2, DQ12 silica; MDSC, Myeloid-derived
suppressor cells; M-MDSC, Monocytic myeloid-derived suppressor cells; PMN-MDSC, Polymorphonuclear
myeloid-derived suppressor cells
* Correspondence: francois.huaux@uclouvain.be
1Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institut de
Recherche Experimentale et Clinique (IREC), Université catholique de
Louvain, Avenue Mounier 53 bte B1.52.12, 1200 Brussels, Belgium
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Huaux et al. Particle and Fibre Toxicology  (2016) 13:46 
DOI 10.1186/s12989-016-0158-0
Background
Excessive inhalation of long and biopersistent fibrous
materials such as asbestos has been associated with the
development of multiple respiratory manifestations, in-
cluding lung cancer and mesothelioma [1]. Concerns
about similar health risks have been expressed for car-
bon nanotubes (CNT). The International Agency for
Cancer Research (IARC) has recently recognized a spe-
cific type of CNT, i.e. Mitsui-7 CNT (CNT-7), as car-
cinogenic in experimental animals [2]. It is, however, not
possible to generalize this carcinogenic property to other
types of CNT due to the lack of coherent experimental
data. There is, therefore, a need to develop bioassays
and biomarkers to predict the carcinogenic activity of
existing, new or emerging CNT.
The currently prevailing paradigm accounting for the
pathogenic activity of carcinogenic fibers such as asbes-
tos or CNT is relatively simple: a chronic inflammatory
status, in which immune cells are activated and release
toxic mediators, damages the pulmonary architecture,
modulates the accumulation of mesenchymal cells and
their connective tissue products, and transforms lung
epithelial or mesothelial cells through direct and indirect
genotoxic and epigenetic pathways [3]. Experimental
monitoring of this inflammatory response can be used to
predict the carcinogenic activity of CNT in short-term
bioassays. In their seminal work, Poland and colleagues
revealed the potential of long straight CNT to induce
mesothelioma by documenting their capacity to elicit an
inflammatory response, similar to asbestos fibres, in the
mouse peritoneal cavity [4].
There is now growing evidence that, besides inflam-
mation, immunosuppressive responses also contribute to
the pathological processes involved in carcinogenesis
and cancer progression [5, 6]. Tumors harbor immuno-
suppressive cells (i.e. regulatory macrophages, mono-
cytes, DC, neutrophils and lymphocytes) that inhibit
both innate and adaptive immunity, subverting immune
surveillance and preventing efficient natural or therapeutic
anti-tumor immune responses [7]. The current under-
standing of immunosuppression in malignant mesotheli-
oma has advanced significantly within the past decade [8].
Tumor-associated immunosuppressive cells include T
regulatory lymphocytes (T regs) and tumor-associated
macrophages (M2 macrophages). Indeed, the stromal space
in primary human mesothelioma tissue harbors significant
proportions of immunosuppressive T regs and M2 macro-
phages that suppress adaptive anti-tumor immunity in this
disease [9, 10].
Myeloid-derived suppressor cells (MDSC) include a small
group of discrete myeloid progenitors and immature cells
morphologically and phenotypically similar to monocytes
(M-MDSC) or polymorphonuclear cells (PMN-MDSC)
[11]. MDSC are currently the focus of intense research
efforts as their accumulation in neoplastic tissues rep-
resents a prognostic marker of tumor progression and
poor therapeutic efficiency [12]. MDSC are generally
associated with established neoplastic tissue, their re-
cruitment being induced by tumor-derived factors [11, 12].
Treatment of mesothelioma-bearing mice with the COX-2
inhibitor celecoxib prevented the local and systemic
expansion of MDSC, suggesting that prostaglandins
such as PGE2 play an important role in the recruitment of
MDSC in established mesothelioma [13]. Immunothera-
peutic approaches targeting MDSC or their immunosup-
pressive function have recently been suggested in patients
with mesothelioma [8].
The direct exposure of mesothelial cells to particles in
the rat peritoneum bioassay is very useful to identify the
capacity of fibrous materials to induce mesotheliomas
[4, 14–16]. While this model does not cover all the
aspects of what occurs in humans occupationally or
environmentally exposed, it allows easily sampling the
mesothelial cavity for studying immune cells associated
with mesotheliomagenesis [4]. We used this model and a
panel of CNT previously characterized for their capacity
to induce or not experimental mesothelioma [17–19] to
define the inflammatory and immunosuppressive func-
tions of accumulated leucocytes after CNT exposure. We
newly show here that M-MDSC are selectively recruited
during the early peritoneal response to carcinogenic CNT,
well before the establishment of mesothelioma.
Results
Monocytic MDSC accompany CNT-induced mesotheliomas
in rats
We first traced MDSC in the peritoneal cavity of rats
treated with carcinogenic multi-walled Mitsui-7 CNT
(CNT-7) known to induce mesotheliomas in Wistar rats,
a strain susceptible to carcinogenic fibers [17–19]. Rats
were treated with a single intra-peritoneal injection of
CNT-7 (6 mg, median length, 7.1 μm; 78 % >5 μm), short
CNT-7 (6 mg, median length, 2.8 μm; 14 % > 5 μm) or cro-
cidolite asbestos [17]. As expected, the first mesotheliomas
occurred 6 months after CNT-7, the majority of animals
developing tumors within 12 months (Fig. 1a). Short CNT-
7 also induced mesotheliomas although to a lesser extent
than the long ones (Fig. 1a). Mesothelioma diagnosis
was confirmed by histological analyses (Additional file 1:
Figure S1 A-F). CNT-7 and short CNT-7 appeared ex-
tremely active in comparison to asbestos fibers over the
12-month duration period (Fig. 1a). One rat injected with
asbestos developed a mesothelioma. This low response to
asbestos after 12 months was consistent with our previous
work in the same rat strain in which the same asbestos
sample did not induce mesothelioma until 14 months
after injection [19]. None of the controls developed meso-
thelioma. Leucocytes were detected in the peritoneal
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lavage performed when rats were euthanized in the course
of the experiment because of clinical evidence of meso-
thelioma (mainly presenting with a dilated abdomen and
ascites) or at terminal sacrifice for rats injected with
CNT-7 or asbestos. Leukocytes were identified by recording
expression of CD11b/c and His48 by flow cytometry
[20, 21]. Monocytic cells and macrophages were the
two main populations present in the peritoneal cavity
of rats bearing mesothelioma after CNT treatment
(Additional file 1: Figure S1 G and I). Compared to con-
trol rats, increased proportions of monocytic CD11b/
cintHis48high cells were noted in animals injected with
CNT-7 (Fig. 1b-c), short CNT-7 or asbestos (Fig. 1 c and





Fig. 1 M-MDSC are specifically accumulated in the peritoneal cavity of rats bearing mesotheliomas after carcinogenic CNT-7 exposure. Incidence
of peritoneal mesotheliomas (a). Flow cytometry dot plots show the proportions of peritoneal leukocyte sub-populations (b) present in the
peritoneal cavity of Wistar rats bearing or not mesotheliomas after carcinogenic CNT-7 (6 mg) or saline (Ctl) treatments and identified by using
CD11b/c and His48 markers (a = macrophages, b = M-MDSC, c = neutrophils, d = granulocytes, i.e. eosinophils and mast cells, as indicated in
CNT-7 square). Proportion of (c) monocytic CD11b/cint and His48high Myeloid Derived Suppressor Cells (M-MDSC) (see b in B), (d) CD11b/cint and
His48int neutrophils (see c in B), (e) CD11b/chigh and His48int macrophages (see a in B), and (f) CD11b/cint and His48low granulocytic cells (see d in
B, eosinophils-mast cells) in peritoneal fluid after saline, CNT-7, short CNT-7 (6 mg) or asbestos (Asb, 2 mg) intra-peritoneally injected in rats. Each
bar represents mean ± SEM. The results were statistically analyzed using the Dunnett’s Multiple Comparison test. ** = p < 0.01, *** = p < 0.001
indicate a statistically significant difference with saline-treated rats (Ctl)
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accumulation was associated with the ability of the fibers
to induce mesotheliomas over the 12 months observation
period (Fig. 1a). In contrast, mesotheliomas were not
associated with an increased proportion of neutrophils
(CD11b/cint and His48int) (Fig. 1d) and macrophages
(CD11b/chigh and His48int) (Fig. 1e). The proportion of
granulocytic cells (eosinophils-mast cells, CD11b/cint and
His48low) was significantly decreased upon mesothelioma-
genic particle exposure (Fig. 1f). We thus concluded that
M-MDSC specifically accumulated in the peritoneal cavity
of rats bearing mesotheliomas induced by CNT.
Early accumulation of M-MDSC in response to carcino-
genic CNT
We next determined the early response to CNT by
examining the time course of peritoneal leukocyte influx
from day 1 to 30. CNT and asbestos (2 mg) induced an
acute accumulation of peritoneal leukocytes after injec-
tion (Additional file 1: Figure S2 A). We found that
monocytic CD11b/cint His48high cells appeared in the
peritoneal cavity as early as 24 h after injection and per-
sisted for at least 30 days (Fig. 2a-b). Monocytic cells
purified from 1 to 30 days after CNT displayed a strong
immunosuppressive activity on spleen T lymphocytes ac-
tivated with anti-CD3/CD28 antibodies (Fig. 2d), con-
firming that this cell population comprised M-MDSC. In
contrast, monocytes purified from blood or peritoneal
cavity of naive rats did not significantly affect activated
T cell proliferation in co-cultures (Additional file 1:
Figure S4 A). A neutrophilic CD11b/cint His48int cell popu-
lation was also recruited at the early stages after CNT ad-
ministration (Fig. 2a and c) but these cells did not display
immunosuppressive activity (Fig. 2e), indicating that they
consisted of inflammatory neutrophils. Like CNT, asbestos
strikingly induced M-MDSC and inflammatory neutrophil
accumulation at all-time points examined (Fig. 2b-c
and f-g). Finally, the proportions of regulatory macro-
phages and other inflammatory granulocytes (eosinophils
and mast cells) were decreased by carcinogenic fiber
treatment (Additional file 1: Figure S3).
We next demonstrated that infiltrated M-MDSC
proliferate as appreciated by BrdU incorporation
(Additional file 1: Figure S4 B) and weakly expressed
the monocyte/macrophage lineage markers CD68 and
CD163 [22] (Additional file 1: Figure S4 C-D). These
observations supported the notion that monocytic cells
recruited after CNT-7 exposure were undifferentiated and
proliferating cells and corresponded to bona fide MDSC.
Finally, we confirmed the inflammatory profile of neutro-
philic cells in CNT-7-treated rats by revealing that
these cells weakly expressed Rp-1 (Additional file 1:
Figure S4 E), a marker of PMN-MDSC in rat mam-
mary carcinoma [21]. Altogether, these results indicated
that, besides the inflammatory reaction (inflammatory
neutrophils), an early accumulation M-MDSC was select-
ively associated with the peritoneal response to carcino-
genic CNT.
Early peritoneal M-MDSC response appears specific for
mesotheliomagenic CNT
We next determined whether M-MDSC were recruited in
mice, which do not develop mesothelioma upon intra-
peritoneal injection of CNT or asbestos fibers [23–25]. In
our hands, conventional C57BL/6 mice did not develop
mesothelioma even after multiple injections of CNT-7
(0.2 mg/mouse/week, not shown). The kinetics of total
leukocyte recruitment in the peritoneal cavity of CNT-
and asbestos-treated mice was similar to that recorded in
rats (Additional file 1: Figure S2 B). The leukocyte sub-
populations were identified in mice by using CCR2 and
Ly6G markers [11]. We found that while the proportions
of monocytic and neutrophilic cells were increased
after CNT-7 and asbestos injections (Additional file 1:
Figure S5 A-C), these cells did not possess a significant and
persistent immunosuppressive activity (Additional file 1:
Figure S5 D-G). Macrophages and granulocytes were not
accumulated after particle treatment and did not affect T
cell proliferation in vitro (Additional file 1: Figure S6).
These data indicated that only inflammatory leukocytes are
recruited in CNT-treated mice. Combining observations in
rats and mice supported, therefore, the idea that the devel-
opment of peritoneal mesotheliomas after CNT exposure
is related to an early recruitment of both inflammatory
neutrophils and M-MDSC.
We further evaluated the specificity of the early M-
MDSC accumulation by comparing their influx at early
time points (days 1 and 7) after a single injection of dif-
ferent agents inducing mesotheliomas (CNT-7, asbestos,
2 mg) or not (silica 2 mg, LPS dose 5 μg) in Wistar rats.
We recorded an inflammatory reaction in all groups as
illustrated by the accumulation of inflammatory neutro-
phils. However, an accumulation of M-MDSC was only
evident in animals treated with CNT-7 or asbestos
(Fig. 3a-c and Additional file 1: Figure S7).
We also compared the capacity of CNT-7 and non-
carcinogenic CNT (CNT-M [19] and CNT-T [17]) at a
dose of 2 mg to acutely recruit M-MDSC in the peri-
toneal cavity of Wistar rats. Only CNT-7 induced an
early and persistent accumulation of M-MDSC while
this influx was weak and transient after CNT-M and
CNT-T (Fig. 3d and Additional file 1: Figure S7).
Altogether, an early and sustained peritoneal M-MDSC
response appeared specific for a mesotheliomagenic CNT.
Discussion
While the mechanistic evidence for a mesothelioma-
genic activity of CNT is still limited, recent experimen-
tal studies have shown that CNT-7 (like asbestos)
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induce peritoneal mesothelioma in rats [17, 18, 26].
These data are challenging because, in humans, malignant
mesothelioma remains highly refractory to existing
therapies [27]. There is, therefore, an urgent need for
additional investigations to identify pathological pathways




Fig. 2 An early accumulation of immunosuppressive M-MDSC is specifically associated with the peritoneal response to carcinogenic CNT-7 in
Wistar rats. a Flow cytometry dot plots show the proportions of leukocyte sub-populations present in peritoneal lavages obtained from CNT-7-
treated rats (2 mg) at day 7 and identified by using CD11b/c and His48 markers (a =macrophages, b = M-MDSC, c = neutrophils, d = granulocytes,
i.e. eosinophils and mast cells). Microscopic views (Diff-Quick staining, 400x) of FACS-sorted monocytic CD11b/cint and His48hi Myeloid Derived
Suppressor Cells (M- MDSC) (b) and CD11b/cint and His48int neutrophils (c) freshly obtained from peritoneal cells of CNT-7-treated rats at day 7.
Proportion of (b) M-MDSC and (c) neutrophils in the peritoneal lavages performed on CNT-7- or crocidolite asbestos- (Asb) treated Wistar rats at
different time points (from 1 to 30 days) after ip injection of 2 mg particles. Each bar represents mean ± SEM of 4–5 observations. The results were
statistically analyzed using the Dunnett’s Multiple Comparison test. ** = p < 0.01, *** = p < 0.001 indicate a statistically significant difference with sa-
line-treated rats (day 0). In vitro anti-proliferative activity of different numbers of M-MDSC (d-f) or neutrophils (e-g) purified at different time points
(from 1 to 30 days) from CNT-7- (d-e) or asbestos- (f-g) treated rats (2 mg) on spleen T lymphocytes activated with anti-CD3/CD28 antibodies. Graphs
represent the average level of 3H-thymidine incorporation expressed as percent of controls (activated T lymphocytes alone) for each M-MDSC or
neutrophils/splenocytes ratio. Each bar represents mean ± SEM. The results were statistically analyzed using the Dunnett’s Multiple Comparison test.
* = p < 0.05, $ = p < 0.01, # = p < 0.001 indicate a statistically significant difference with activated splenocytes cultured alone
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biomarkers predicting the carcinogenic activity of newly
developed CNT.
Major advances in understanding the mechanisms
leading to tumor immunity have recently been made
[28–30]. The development of cancers is now viewed as re-
lated to the ability of tumors to develop a tolerant micro-
environment by activating diverse immunosuppressive
mechanisms counteracting antitumor host immunity [31].
Previous studies have indicated that immunosuppressive
responses in mesothelioma consist of tumor-induced
accumulation of regulatory T lymphocytes (Tregs) and
immature myeloid cells [32]. By using orthotopic implant-
ation of established mesothelioma cell lines in syngenic
mice, it has been reported that tumor-associated Tregs
contribute to mesothelioma development by limiting
the accumulation of IFN-gamma producing effector T
C
D
Fig. 3 The early peritoneal M-MDSC response is specific of mesotheliomagenic CNT. Proportion of (a) monocytic CD11b/cint and His48hi Myeloid
Derived Suppressor Cells (M-MDSC) and (b) inflammatory CD11b/cint and His48int neutrophils in the peritoneal lavages performed on saline-, CNT-
7- (2 mg), crocidolite asbestos- (Asb, 2 mg), DQ12 silica- (SiO2, 2 mg) or LPS- (E. coli, 5 μg) treated Wistar rats 1 day after ip injection. SiO2 and LPS
are not mesotheliomagenic. c Proportion of peritoneal M-MDSC after ip injection of 2 mg CNT-7, short CNT-7 or asbestos at day 1. Each bar repre-
sents mean ± SEM of 4–5 observations. The results were statistically analyzed using the Dunnett’s Multiple Comparison test. * = p < 0.05, ** = p <
0.01, *** = p < 0.001 indicate a statistically significant difference with saline-treated rats (Ctl). d Proportion of peritoneal M-MDSC in the peritoneal
cavity of rats after carcinogenic CNT-7 or non-carcinogenic CNT-M or CNT-T treatment (2 mg) at days 7, 15 and 30. The results were statistically
analyzed using the Dunnett’s Multiple Comparison test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 indicate a statistically significant difference
between saline-treated (day 0) and CNT-7-treated animals. ## = p < 0.01 indicates a statistically significant difference between saline-treated
(day 0) and CNT-T-treated animals. $$ = p < 0.01 indicates a statistically significant difference between saline-treated (day 0) and
CNT-M-treated animals
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lymphocytes [9, 33]. COX-2-dependent MDSC have also
been reported in established mesothelioma [13, 34]. In a
mouse model of lung carcinoma, CNT increased the re-
cruitment and accumulation of tumor-associated MDSC
that produced TGFβ and increased lung tumor burden
[35, 36]. Our data demonstrate for the first time that car-
cinogenic CNT possess the intrinsic capacity to induce a
selective, rapid and sustained accumulation of monocytic
MDSC before mesothelioma is established. This unsus-
pected observation indicates that a suitable environ-
ment for tumoral cell evasion from T cell surveillance
is rapidly installed (within the first days) after carcino-
genic CNT exposure. M-MDSC can be generated in the
bone marrow in response to factors such as colony stimu-
lating factors (CSFs), inflammatory cytokines and vascular
endothelial growth factors and are recruited through a
gradient of chemokines such as CCL2. Resident peritoneal
macrophages and mesothelial cells treated in vitro with as-
bestos or CNT release these MDSC-related factors [37,
38]. Our data also revealed that beside monocytic cells,
peritoneal macrophages also possess immunosuppressive
functions upon CNT treatment (Additional file 1: Figure
S3). The immunosuppressive M-MDSC and macrophages
may thus represent a new crucial pathological pathway in
CNT-induced mesothelioma. Our observation also
showed that M-MDSC weakly expressed the markers of
the classical monocyte/macrophage lineage CD68 and
CD163. Previous study also demonstrated that tumor-
associated macrophages are not related to MDSC in ex-
perimental mesothelioma [39]. Altogether, these data sug-
gest that monocytic cells weakly differentiate in
macrophages and that other mechanisms explain macro-
phage accumulation during peritoneal responses to CNT.
Interestingly, it has been demonstrated that macrophages
self-maintain independently of monocytes in response to
IL-1α released after silica instillation [40] and hypothetic-
ally after intra-peritoneal administration of CNT. Regula-
tory neutrophilic MDSC (PMN-MDSC) that highly
express Rp-1, a marker of undifferentiated neutrophils,
have been detected in rat bearing carcinoma [21]. In con-
trast, neutrophils accumulated locally after short-term ex-
posure to mesotheliomagenic CNT are ineffective for
inhibiting T cell proliferation and weakly express Rp-1. It
remains, however, to determine whether regulatory Rp-1+
PMN-MDSC infiltrate mesotheliomas in long-term stud-
ies with CNT-treated rats as proposed in other models
[41].
In recent years, experimental observations have sup-
ported a scenario whereby a series of chronic and diverse
cell injuries and immune stimuli explain the long latency
period of mesothelioma development. It thus is probable
that the persistent accumulation of M-MDSC represents
one of the immune components contributing to meso-
thelioma development. Indeed, considerable evidence
also suggests that inflammatory neutrophils play a critical
role in cancer progression. Early in the neoplastic process,
neutrophils trigger genomic instability, produce a favorable
environment for tumor growth, and promote angiogenesis
[42]. Neutrophils accumulated after asbestos generate sub-
stantial amounts of DNA damaging free-radicals [43]. The
neutrophil influx in the peritoneal cavity of CNT-treated
animals therefore contributes to explain the carcinogen-
icity of CNT and has been proposed as an early biomarker
for predicting the carcinogenic activity of CNT [3, 4].
We confirmed here that inflammatory neutrophils are
massively and early recruited after CNT or asbestos
injection. The joint presence of immunosuppressive M-
MDSC and inflammatory neutrophils supports a sce-
nario in which synchronized immunosuppressive and
inflammatory mechanisms contribute to the emergence
of neoplastic cells, induce immunological tolerance
allowing tumor cell evasion, and finally promote tumor
progression. In contrast to M-MDSC, we noted that the
accumulation of inflammatory neutrophils was not spe-
cific for mesotheliomagenic agents because silica or LPS
similarly induced an acute accumulation of neutrophils.
Thus, the early and sustained accumulation of M-MDSC
after carcinogenic CNT treatment may represent a more
robust indicator of a potential to induce mesothelioma
than solely the inflammatory neutrophil response. The
capacity of a given CNT to maintain a sustained M-
MDSC response probably integrates its biopersistence,
which is an important parameter determining the carcino-
genic potential of CNT and fibers [3].
Conclusion
Our data provide new insight on how CNT may estab-
lish a carcinogenic response by mounting an early and
sustained immunosuppressive microenvironment facili-
tating, in conjunction with inflammation, mesothelioma
development. M-MDSC represent a new component of
the adverse outcome pathway leading to the develop-
ment of mesothelioma. The specificity of the M-MDSC
accumulation after exposure to carcinogenic CNT high-
lights the potential interest of this response for detecting
in short-term bioassays the ability of new or emerging
CNT to cause mesothelioma.
Methods
Carbon nanotubes and asbestos fibers
CNT-7 were multi-walled carbon nanotubes MWCNT-
XNRI-7 from Mitsui & co (Ltd., Tokyo, Japan, Lot#
05072001 K28) sub-sampled at Norwegian Research
Centre for the Working Environment (NRCWE) with the
code NRCWE-006. Short CNT-7 were obtained by grind-
ing CNT-7 in an oscillatory agate ball mill (Pulverisette 0,
Fritsch), with a vertical vibration of 1 mm applied
during 6 h. CNT-7 and short CNT-7 were annealed at
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1500 °C under argon during 60 min. Multi-walled CNT-
M (Muller) and CNT-T (tangled, kindly provided by prof
S. Toyokuni, Nagoya university, Japan) and their physico-
chemical characteristics have been documented in details
previously [17, 19, 44]. The main characteristics of CNT-7,
short CNT-7 and CNT-M are summarized in the Additional
file 2: Table S1. Respirable crocidolite fibers (positive con-
trol) were obtained from the Union internationale contre
le Cancer (UICC, Geneva, Switzerland) [45]. All particles
were first treated at 200 °C during 2 h to remove any pos-
sible trace of endotoxin and suspensions were prepared
immediately before administration by sonication and man-
ual vortexing in sterile phosphate-buffered saline (PBS) con-
taining 1.4 mg bovine serum albumin/ml.
Animals
Specific pathogen free (SPF) male Wistar rats (10 weeks
old, 200 g) were obtained from Charles River (Brussels,
Belgium). C57BL/6 mice (10 weeks old, 20 g) were
purchased from Janvier SAS (St Berthevin, France).
International recommendations for doses administered,
controls and group size were followed [46]. After a week
of acclimatization, the animals were injected intraperito-
neally with the different particles suspended in a volume
of 2 ml (rats) or 0.5 ml (mice) of PBS-BSA. For long-term
experiments (12 months), groups of 50 rats were injected
with 6 mg of CNT-7 (2*109 WHO fibres), short CNT-7
(0.36*109 WHO fibres). Positive controls were injected
with 2 mg (6*109 WHO fibres) of crocidolite asbestos
(n = 26). Vehicle controls (n = 26) were injected with an
equal volume of PBS-BSA. The animals were housed at
the local animal facility under SPF conditions, with a 12-h
light–dark cycle and controlled temperature and humidity.
They were given tap water and sterilized pellets ad
libitum. The animals were observed daily for mortality/
morbidity and debilitated animals were euthanized with
an intra-muscular injection of pentobarbital. Full gross
necropsy was performed on all animals found dead or eu-
thanized during the experiment, and grossly visible lesions
or tumors were preserved in 10 % formalin. The experi-
ment was terminated after 12 months when the majority
of the animals injected with CNT-7 or short CNT-7 had
developed tumors. At this point in time, positive control
animals were not justified anymore and we sacrificed the
rats treated with crocidolite before they had devel-
oped tumors, except one. All animals were sacrificed
and systematically autopsied. External lesions and tumors
were recorded and samples were preserved for subsequent
histopathological analysis. The peritoneal cavity was opened
and the cells present in the peritoneal fluid were collected
and analyzed (see below). Then, the peritoneal cavity was
examined macroscopically for the presence of anomalies
and tissues were preserved in formalin for histopathological
examination.
In short-term experiments to analyze cellular responses,
groups of 4 to 5 Wistar rats or C57BL/6 mice were
injected with 2 mg (rats) or 0.2 mg (mice) of test material
and sacrificed after 1, 7, 15 and 30 days. In these condi-
tions, injection in rats of 2 mg CNT-7 corresponds to
0.67*109 WHO fibres, 2 mg short CNT-7 to 0.12*109
WHO fibres and 2 mg crocidolite asbestos to 6*109 WHO
fibres. In mice, 0.67 108 WHO fibres of CNT-7 (0.2 mg)
were injected per animal.
Histopathological analysis
The different tissues were processed for light micro-
scopic examination by serial desiccation in ethanol and
paraffin embedded specimens were cut in 5-μm slices
and stained with hematoxylin-eosin (HE). The prepara-
tions were examined by an experienced pathologist.
Cell analysis and purification
The peritoneal cavity was lavaged with 15 ml (rats) or
8 ml (mice) of saline, and leukocyte counts were deter-
mined on a Burker cell chamber. Cytocentrifuge prepa-
rations of peritoneal cells were stained with Diff-Quick
(Baxter, Lessines, Belgium). Rat peritoneal cell suspen-
sions were also stained using antibodies specific for
CD11b/c-APC (clone OX-42) obtained from BioLegend
(San Diego, USA), His48-FITC (clone anti-granulocytes)
from eBioscience (Hatfield, UK), CCR2-PE (clone 890231)
from R&D system (Abingdon, UK), CD68 and CD163
(AbD Serotec, Oxford, UK), Rp-1 (BD Pharmingen,
Erembodegem, Belgium) and isotype controls (clone
MOPC-21, MCA1209F, 11E10 and MG2a) from BioLe-
gend, Gentaur (Kampenhout, Belgium), eBioscience and
Invitrogen (Frederick, USA). Mouse peritoneal cells were
stained by the following antibodies: CD45-PerCp Cy5.5
(clone 30-F11), CD11b-BV 421 (clone M1/70), Ly6G-
FITC (clone 1A8) from BD Biosciences (Erembodegem,
Belgium), CCR2-PE (clone 475301) from R&D Systems
and isotype controls (clone R35-95, A95-1) from BD Bio-
sciences. Samples were fixed in a 1.25 % paraformaldehyde
in PBS, acquired on a FACSCalibur (BD Biosciences) and
analyzed using the FlowJo software. Rat and mouse peri-
toneal leukocytes were separated and isolated using flow
cytometry cell sorting (FACSAria III, BD Biosciences).
APC (CD11b/c), FITC (His48) and PE (CCR2) fluores-
cence measured by FACS was used to select rat peritoneal
cell subpopulations and PerCP-Cy5.5 (CD45), BV 421
(CD11b), FITC (Ly6G), and PE (CCR2) fluorescence to se-
lect mouse peritoneal cell subpopulations The purity of
the obtained leukocyte cell preparations was routinely
>93 % as assessed by Diff-Quick staining.
BrdU incorporation
15 mg of BrdU (BD Biosciences) was injected intraperito-
neally in rats 24 h before the sacrifice (7 days after saline
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or CNT-7 treatment, 2 mg). Cell suspensions from the
peritoneal cavity were stained for surface markers followed
by intracellular BrdU staining using the BrdU Flow
kit according to the manufacturer’s instructions (BD Bio-
sciences). Stained cells were acquired on a FACSCalibur
(BD Biosciences) and analyzed using the CellQuest
software (BD Biosciences).
Immunosuppressive in vitro test
The suppressive activity on T lymphocytes of peritoneal
leukocyte subpopulations was assessed in a co-culture
assay in which splenocytes from 3 naive rats or mice
were pooled and seeded in triplicates in 96-well round
bottom plates (50× 103/well, Cellstar®, 96 well, U-Botto,
Greiner Bio-One, Wemmel, Belgium). Splenocytes were
cultured in the presence of increasing ratios of rat or
mouse purified peritoneal cells and stimulated with anti-
CD3 (anti-rat clone G4.18, anti-mouse clone 145-2C11,
5 μg/ml, BD Biosciences) and anti-CD28 (anti-rat clone
JJ319, anti-mouse clone 37.51, 2 μg/ml, BD Biosciences)
antibodies. On day 3 of the co-culture, cells were pulsed
with 3[H]-thymidine (0.05 mCi per well, Perkin Elmer,
Waltham, USA) and 18 h later 3[H]-thymidine incorpor-
ation was assessed.
Statistics
Data were evaluated by one-way analysis of variance
(ANOVA) using the Dunnett’s Multiple Comparison
Test when appropriate. Statistical significance was con-
sidered at p < 0.05.
Additional files
Additional file 1: Figure S1. Mesotheliomas and leucocytes in
peritoneal cavity of Wistar rats after mesotheliomagenic CNT-7 exposure.
Figure S2. Peritoneal cell numbers after CNT and asbestos treatment in
rats and mice. Figure S3. Proportions and in vitro activity of macrophages
and granulocytes during the early peritoneal response to carcinogenic
CNT-7 in Wistar rats. Figure S4. Characterization of peritoneal M-MDSC and
inflammatory neutrophils accumulated after CNT-7 injection in Wistar rats.
Figure S5. Accumulation of inflammatory monocytes and neutrophils
during the peritoneal response to carcinogenic CNT-7 in C57BL/6 mice.
Figure S6. Proportions and in vitro activity of macrophages and granulocytes
during the early peritoneal response to carcinogenic CNT-7 in C57BL/6
mice. Figure S7. Early peritoneal M-MDSC response is specific of
mesotheliomagenic CNT in Wistar rats. (PPTX 5835 kb)
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